Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Net Income From Continuing Operations : ₺455 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's net income from continuing operations for the three months ended in Dec. 2023 was ₺-135 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was ₺455 Mil.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Net Income From Continuing Operations Historical Data

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Net Income From Continuing Operations Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

143.12

207.04

310.37

639.95

454.58

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
	Dec18	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Income From Continuing Operations	Get a 7-Day Free Trial												-24.24	105.36	167.24	316.51	-134.53

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺455 Mil.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520

Website

https://www.genilac.com.tr

Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Headlines

No Headlines